Stock Split Watch: Is Eli Lilly Next?

Eli Lilly (LLY), a pharmaceutical firm, has seen its stock soar over 300% in the past five years, reaching levels above $1,200. This has sparked speculation about a potential stock split. Stock splits involve issuing additional shares to existing shareholders, which lowers each share's price proportionally. This makes the stock more accessible to a wider range of investors and can make it seem less expensive.

Eli Lilly has a history of stock splits, having conducted four in the past, though the last one was nearly three decades ago. Currently, the company's stock is trading at $1,160, and recent momentum, driven by the launch of a new weight loss drug GLP-1 pill Foundayo, could signal a future split. However, it's crucial to note that stock splits don't fundamentally alter a company's value or performance.